tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bayer upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe FlyBayer upgraded to Overweight from Equal Weight at Morgan Stanley
20d ago
Bayer welcomes Solicitor General support for U.S. Supreme Court review
Premium
The Fly
Bayer welcomes Solicitor General support for U.S. Supreme Court review
21d ago
Bayer starts SUNFLOWER study
Premium
The Fly
Bayer starts SUNFLOWER study
21d ago
Bayer’s Asundexian met primary efficacy, safety endpoints in Phase III study
PremiumThe FlyBayer’s Asundexian met primary efficacy, safety endpoints in Phase III study
30d ago
Bayer announces FDA approval of Hyrnuo for non-small cell lung cancer
Premium
The Fly
Bayer announces FDA approval of Hyrnuo for non-small cell lung cancer
1M ago
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell
Premium
The Fly
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell
1M ago
Bayer reports Q3 core EPS EUR 0.57 vs. EUR 0.24 last year
PremiumThe FlyBayer reports Q3 core EPS EUR 0.57 vs. EUR 0.24 last year
1M ago
Bayer expects to ‘significantly contain’ litigation risk by end of 2026
Premium
The Fly
Bayer expects to ‘significantly contain’ litigation risk by end of 2026
1M ago
Bayer confirms group guidance for 2025
Premium
The Fly
Bayer confirms group guidance for 2025
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100